荣昌生物制药(烟台)股份有限公司 关于召开2025年第三次临时股东会的通知

Core Points - The company will hold its third extraordinary general meeting of shareholders on December 2, 2025 [2][23] - The meeting will utilize both on-site and online voting methods [4][7] - The company has proposed amendments to several governance systems, which require shareholder approval [20][21] Group 1: Meeting Details - The extraordinary general meeting is scheduled for December 2, 2025, at 14:00 [2] - Voting will be conducted through the Shanghai Stock Exchange's online voting system, with specific time slots for trading system voting [2][4] - Shareholders must register in advance to attend the meeting, with registration open on December 1, 2025 [11][12] Group 2: Voting Procedures - Shareholders can vote via the trading system or the internet voting platform, with identity verification required for first-time users [7][8] - Duplicate votes through different methods will be counted based on the first submission [8] - All proposals must be voted on before submission [9] Group 3: Governance Amendments - The board has approved amendments to several governance systems, including management of related transactions and external guarantees [20][21] - These amendments will be presented for shareholder approval at the upcoming meeting [21][26] - The board meeting that approved these amendments was held on November 13, 2025, with full attendance [20][22]